NT$259.50
NT$-0.50 (-0.19%)
End-of-day quote: 05/14/2024
TWSE:5434
Topco Scientific Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
NT$49.27B | NT$52.98B | NT$42.67B | NT$36.17B | NT$31.70B | NT$28.86B | NT$23.78B | NT$22.63B | NT$19.08B | NT$18.09B | NT$15.55B | |
| GM % | Gross Margin % |
|
13.03% | 12.32% | 12.22% | 11.90% | 12.36% | 11.79% | 12.36% | 12.90% | 12.77% | 11.98% | 12.62% | |
| OM | Operating Margin |
|
6.49% | 6.10% | 5.98% | 5.70% | 5.82% | 5.27% | 5.10% | 6.02% | 5.60% | 5.07% | 5.70% | |
| EPS | Earnings Per Share |
|
NT$0.00 | NT$15.36 | NT$16.41 | NT$12.53 | NT$11.29 | NT$9.42 | NT$7.68 | NT$5.95 | NT$7.21 | NT$5.73 | NT$5.14 | NT$4.72 |
| Div. | Dividends |
|
NT$9.00 | NT$10.00 | NT$8.80 | NT$8.00 | NT$6.50 | NT$5.30 | NT$4.20 | NT$5.00 | NT$0.00 | NT$0.00 | NT$0.00 | |
| PR % | Payout Ratio % |
|
58.59% | 60.94% | 70.23% | 70.86% | 69.00% | 69.01% | 70.59% | 69.35% | 0 | 0 | 0 | |
| Sha. | Shares |
|
188.7m | 181.7m | 181.7m | 181.7m | 181.7m | 181.7m | 181.7m | 165.9m | 165.9m | 165.9m | 165.9m | |
| OCF | Operating Cash Flow |
|
NT$1.62B | NT$3.18B | NT$2.60B | NT$2.01B | NT$1.76B | NT$1.09B | NT$823.67M | NT$1.73B | NT$710.06M | NT$1.05B | NT$693.93M | |
| FCF | Free Cash Flow |
|
NT$206.00M | NT$2.81B | NT$2.19B | NT$1.73B | NT$1.45B | NT$815.74M | NT$338.53M | NT$1.06B | NT$83.65M | NT$393.31M | NT$429.14M | |
| FCFS | Free Cash Flow Per Share |
|
NT$-1.06 | NT$15.36 | NT$12.00 | NT$9.49 | NT$7.93 | NT$4.42 | NT$1.89 | NT$6.39 | NT$0.42 | NT$2.37 | NT$2.17 |
